Navigation Links
Pevion Grants CSL Option Right to its Therapeutic Candida Vaccine
Date:9/1/2011

y that fulfills carrier and adjuvant functions in one. Essentially, virosomes represent reconstituted empty influenza virus envelopes, devoid of the genetic material of the source virus. As such, virosomes do not replicate and are therefore an ideal combination of carrier plus adjuvant for almost any given antigen, including peptide or protein derived antigens. The technology enables the use of poorly immunogenic antigens and thereby provides access to new indications and markets. Two virosome-based vaccines (Epaxal® and Inflexal® V, marketed by Crucell Switzerland AG) are licensed in over 40 countries, and more than 70 million doses of these vaccines have been commercially distributed, thereby providing a solid safety and efficacy track record. Pevion has developed the second generation of virosomes that allow alternative product formulations, such as capsules.

About Pevion Biotech AG

Pevion Biotech AG is a fully independent Swiss vaccine company that develops innovative vaccines for unmet medical needs based on its clinically and commercially validated virosome technology. Its proprietary clinical pipeline includes a first-in-class candidiasis vaccine. A clinical stage malaria vaccine candidate has been successfully outlicensed, and the Company's technology has been licensed for use as an HIV vaccine currently in human trials. Pevion has in-house development capability and expertise, including a state-of-the-art and industrially scalable GMP manufacturing process. Located near Bern, Pevion was established by its founding fathers, Bachem AG (SWX: BANB) and Berna Biotech (now Crucell, a Johnson & Johnson subsidiary). To date, Pevion has raised a total of CHF 45 million from its founders and investors, BZ Bank, Core Capital Parnters and BB Biotech Ventures.

For more information visit: http://www.pevion.com

Julian Wagner, PhD,
Business Development
Phone: +41-31-550-44-44

'/>"/>

SOURCE Pevion Biotech AG
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Pevions Breakthrough Candida Vaccine Demonstrates Safety and Immunogenicity in Phase I Clinical Study
2. Pevion Biotech Appoints New CEO and Secures CHF 10 Million Financing
3. Muscular Dystrophy Association Awards $13.7 Million for 40 New Research Grants
4. FDA Grants Fast Track Designation to Bayers Investigational Compound Radium-223 Chloride for the Treatment of Castration-Resistant Prostate Cancer That Has Spread to the Bone
5. Echo Therapeutics Announces Multiple Patents and Trademark Grants
6. FDA Grants Orphan Drug Status to Merrimack Pharmaceuticals MM-398, a Nanotherapeutic Encapsulation of Irinotecan, for the Treatment of Pancreatic Cancer
7. UCLA Receives Six UC Health Quality Grants to Improve Hospital Care
8. China Grants COPAN Patent for Flocked Swabs
9. Edison Pharmaceuticals Announces FDA Grants EPI-743 Orphan Drug Designation
10. Optimer Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
11. FDA Formally Accepts Dune Medicals MarginProbe™ System Pre-Market Approval (PMA) Application and Grants Expedited Review Status
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... -- According to data released today by the Centers for ... Part D premium is expected to remain stable at ... the Pharmaceutical Care Management Association (PCMA) said. ... bright spot in American health care. By offering an ... cutting edge, cost-saving tools like pharmacy networks and home ...
(Date:7/31/2014)... -- ResMed Inc. (NYSE: RMD ) today announced results ... June 30, 2014.  Revenue for the quarter was $415.2 million, ... 1 percent decrease on a constant currency basis). Net income ... the quarter ended June 30, 2013. Diluted earnings per share ... compared to the quarter ended June 30, 2013.  ...
(Date:7/31/2014)... 31, 2014  Cepheid (NASDAQ: CPHD ) today ... conferences, and invited investors to participate via webcast. ... New York, NY Wednesday, August 13, 2014 at ... Conference, New York, NY Thursday, September ... Accessing Live Webcasts To access the live webcasts for these ...
Breaking Medicine Technology:RESMED Inc. Announces Results for the Fourth Quarter and Fiscal Year 2014 2RESMED Inc. Announces Results for the Fourth Quarter and Fiscal Year 2014 3RESMED Inc. Announces Results for the Fourth Quarter and Fiscal Year 2014 4RESMED Inc. Announces Results for the Fourth Quarter and Fiscal Year 2014 5RESMED Inc. Announces Results for the Fourth Quarter and Fiscal Year 2014 6RESMED Inc. Announces Results for the Fourth Quarter and Fiscal Year 2014 7RESMED Inc. Announces Results for the Fourth Quarter and Fiscal Year 2014 8RESMED Inc. Announces Results for the Fourth Quarter and Fiscal Year 2014 9RESMED Inc. Announces Results for the Fourth Quarter and Fiscal Year 2014 10RESMED Inc. Announces Results for the Fourth Quarter and Fiscal Year 2014 11RESMED Inc. Announces Results for the Fourth Quarter and Fiscal Year 2014 12RESMED Inc. Announces Results for the Fourth Quarter and Fiscal Year 2014 13Cepheid to Webcast Upcoming Financial Presentations 2
... Inc. (NASDAQ: IDIX ), a biopharmaceutical company ... the treatment of human viral diseases, today announced that ... and Lead Director of Idenix,s Board and former President ... as Chairman of the Board. Additionally, Idenix has appointed ...
... Inc. (NASDAQ: AVNR ) today announced that company management ... & Company Healthcare Conference , Location: Boston Marriott, Boston , MA ... a.m. ET , 2012 Roth OC Growth ... Date: Tuesday March 13, 2012 , Presentation time: 4:30 p.m. PT ...
Cached Medicine Technology:Idenix Pharmaceuticals Elects Thomas Hodgson as Chairman of the Board and Appoints Michael Wyzga to Its Board of Directors 2
(Date:8/1/2014)... (GSA) the nation,s largest interdisciplinary organization devoted to ... Lewis, PT, DPT, PhD, GTC, GCS, MSG, MPA, FAPTA, ... of Aging Persons Award. , This distinguished honor is ... of rehabilitation. The awardee,s work may be in the ... may include scholarly works, books, monographs, administrative directives, or ...
(Date:8/1/2014)... According to Forrester Research, more than 90 percent of ... of information, and thanks to the launching of DCInsurers Agent ... resources on insurance specifically for the state of Colorado can ... step in the growth of our business,” Doug King, owner/agent ... Insurance Resources office. “We recognize that the web is how ...
(Date:8/1/2014)... August 01, 2014 Frontier Nursing University ... and Services Administration’s Advanced Education Nursing Traineeship (AENT) ... provide direct support to 280 students over the grant ... Program is to increase the number of advanced education ... nursing faculty to address the nurse faculty shortage that ...
(Date:8/1/2014)... Bioengineering and Nanotechnology (IBN), Singapore General Hospital (SGH) ... the first molecular test kit that can predict ... This breakthrough was recently reported in European ... , According to IBN Executive Director Professor Jackie ... diagnostics and cancer research, we have developed the ...
(Date:8/1/2014)... August 01, 2014 St. Christopher's Hospital ... an upcoming episode of Innovations with Ed Begley Jr, ... and show times TBA. , St. Christopher's Hospital for ... for children from birth through 21 years of age. ... of the hospital's specialties, including autism and childhood obesity. ...
Breaking Medicine News(10 mins):Health News:Lewis to receive GSA's 2014 Excellence in Rehabilitation of Aging Persons Award 2Health News:DCInsurers Agent Doug King Launches a New Website 2Health News:DCInsurers Agent Doug King Launches a New Website 3Health News:Frontier Nursing University Receives $700,000 in Scholarships for Advanced Practice Nursing and Midwifery Students 2Health News:Taking the guesswork out of cancer therapy 2Health News:Taking the guesswork out of cancer therapy 3Health News:Innovations with Ed Begley, Jr. to Feature St. Christopher's Hospital for Children in Upcoming Episode 2Health News:Innovations with Ed Begley, Jr. to Feature St. Christopher's Hospital for Children in Upcoming Episode 3
... Facilities Treated with the Antimicrobial Protection of the ... SportsAide(R) System from SportCoatings(TM), EAST ... are,the next team in the NBA scoring with the ... antimicrobial contamination. SportsAide is part of the Sports ...
... Meeting Expectations today announced,that it has been named ... the industry,s,largest and most influential full-service independent meeting ... market. Compiled by,Penton Media,s Corporate Meetings & Incentives(R) ... corporate meetings and events,industry, the CMI 25 provides ...
... putting patients with heart disease at risk by affecting blood ... the University of Edinburgh and Ume University measured the effects ... men who have previously experienced a heart attack. , ... in the New England Journal of Medicine, found that inhalation ...
... showed effect after brief exposure to diesel exhaust , , ... not to take your daily jog during rush ... exposed, even briefly, to diesel exhaust fumes showed reduced blood ... various cardiovascular problems, including heart attacks and arrhythmias. , The ...
... Sept. 12 Having already made great,strides in ... is,ready to take on America. Terumo Interventional ... Coronary Guidewire to the U.S. market. With its ... this,coronary guidewire boasts efficiency and reliability unlike that ...
... Alliance,for Hispanic Health (the Alliance) is launching a ... (Presion alta...El control,esta en tus manos) with the ... promoting prevention, and helping Hispanic adults bring,their high ... and blood pressure screening events in San Antonio ...
Cached Medicine News:Health News:New Jersey Nets Shoot Down Staph with High-Tech Defense 2Health News:Meeting Expectations Named to First Annual 'CMI 25' List by Corporate Meetings & Incentives Magazine 2Health News:Diesel exhaust may increase risk in patients with heart disease 2Health News:Jogging in Traffic Cuts Blood Flow to Heart 2Health News:Jogging in Traffic Cuts Blood Flow to Heart 3Health News:Proven Terumo Coronary Guidewire Technology Is Now Available in the United States 2Health News:Proven Terumo Coronary Guidewire Technology Is Now Available in the United States 3Health News:Uncontrolled Blood Pressure Highest Among Hispanics, Prompting New Hypertension Project in San Antonio 2Health News:Uncontrolled Blood Pressure Highest Among Hispanics, Prompting New Hypertension Project in San Antonio 3
... lens available for gonioscopy ... 62 mirror. Tilted anterior ... laser beam astigmatism. Unsurpassed ... on most patients without ...
West lacrimal cannula blunt tip with side port....
West lachrymal cannula, blunt tip with inner side opening, gently curved shaft....
McIntyre lacrimal cannula, dual 0.3 mm side ports, straight....
Medicine Products: